Literature DB >> 21052954

Meta-analysis of randomized controlled trials of granulocyte colony-stimulating factor prophylaxis in adult cancer patients receiving chemotherapy.

Nicole M Kuderer1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21052954     DOI: 10.1007/978-1-4419-7073-2_8

Source DB:  PubMed          Journal:  Cancer Treat Res        ISSN: 0927-3042


× No keyword cloud information.
  3 in total

1.  A pharmacokinetics and pharmacodynamics equivalence trial of the proposed pegfilgrastim biosimilar, MYL-1401H, versus reference pegfilgrastim.

Authors:  Cornelius F Waller; Renger G Tiessen; Tracey E Lawrence; Andrew Shaw; Mark Shiyao Liu; Rajiv Sharma; Mark Baczkowski; Mudgal A Kothekar; Catherine E Micales; Abhijit Barve; Gopinath M Ranganna; Eduardo J Pennella
Journal:  J Cancer Res Clin Oncol       Date:  2018-04-18       Impact factor: 4.553

2.  A prospective study to evaluate febrile neutropenia incidence in patients receiving pegfilgrastim on-body injector vs other choices.

Authors:  Robert M Rifkin; Jeffrey Crawford; Reshma L Mahtani; David C Dale; Mohit Narang; William W MacLaughlin; Chanh Huynh; Prasad L Gawade; Sandra Lewis; Lucy DeCosta; Tatiana Lawrence; Rajesh Belani
Journal:  Support Care Cancer       Date:  2022-06-22       Impact factor: 3.359

3.  Biosimilar filgrastim vs filgrastim: a multicenter nationwide observational bioequivalence study in patients with chemotherapy-induced neutropenia.

Authors:  Alper Sevinç; Metin Özkan; Ahmet Özet; Faysal Dane; Berna Öksüzoğlu; Abdurrahman Işıkdoğan; Feyyaz Özdemir; Doğan Uncu; Mahmut Gümüş; Türkkan Evrensel; Arzu Yaren; Oğuz Kara; Salim Başol Tekin
Journal:  Onco Targets Ther       Date:  2018-01-18       Impact factor: 4.147

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.